News Roundup | Nasal Spray For COVID-19? No Mention in Big Media

Join The Conversation! | https://trialsitenews.com/
Article | Nasal Spray For COVID-19? No Mention in Big Media
At the start of 2021 TrialSite News reported on UK-based NHS hospitals involved with a clinical trial involving a nasal spray that in a lab environment exhibited the ability to kill 99.9% of SARS-Cov-2, the virus behind COVID-19. Called the SaNOTize Nitric Oxide Nasal Spray (NONS), this investigational product was designed to kill COVID-19 in the upper airways, in effect inhibiting the virus from incubating and thereby making its way to the host’s lungs. The product was developed by Vancouver, Canada-based SaNOtize Research and Development Corp, based on results from lab tests at Utah State University’s Antiviral Research Institute. By the summer of 2021 the product was evidencing positive results in Phase 2 clinical trials. The investigational product was so promising that some countries, including Israel have allowed the product into pharmacies.

Link | https://trialsitenews.com/nasal-spray-kills-covid-19-now-approved-in-india-israel-bahrain-indonesia-thailand-no-mention-in-big-media/